Akash Nanda

Summary

Publications

  1. ncbi request reprint Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease
    Akash Nanda
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL, USA Electronic address
    Eur Urol 65:177-85. 2014
  2. doi request reprint Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy
    Akash Nanda
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, Florida, USA
    Int J Radiat Oncol Biol Phys 85:e209-15. 2013

Collaborators

Detail Information

Publications2

  1. ncbi request reprint Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease
    Akash Nanda
    Department of Radiation Oncology, M D Anderson Cancer Center Orlando, Orlando, FL, USA Electronic address
    Eur Urol 65:177-85. 2014
    ..However, its effect in men with no or at least a single risk factor for CAD stratified by prostate cancer (PCa) aggressiveness is unknown...
  2. doi request reprint Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy
    Akash Nanda
    Department of Radiation Oncology, MD Anderson Cancer Center Orlando, Orlando, Florida, USA
    Int J Radiat Oncol Biol Phys 85:e209-15. 2013
    ..To assess the impact of coronary artery disease (CAD) risk factors and sequelae on the risk of all-cause mortality (ACM) in men treated for prostate cancer (PC)...